← Eichor
Study identifier: NCT05536505 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC

Condition: MRD  ·  Sponsor: Guangdong Association of Clinical Trials

PhasePhase 2
Planned participants180
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

A prospective, multicenter clinical study designed to explore the efficacy of postoperative adjuvant EGFR-TKIs therapy based on MRD status in patients with stage IB-IIIB EGFR-mutant non-squamous non-small cell lung cancer (non-squamous NSCLC). Primary endpoints include 3-year Disease-Free Survival rate (3y-DFS) and median disease-free survival (mDFS).

This description comes directly from the study's public registry record.

Talk to the study team

Yi-Long Wu, MD  ·  020-83827812  ·  syylwu@live.cn

Ri-Qiang Liao

Always discuss trial participation with your own doctor first.

Locations (16)

Beijing Friendship Hospital, Capital Medical UniversityBeijing, ChinaNot Yet Recruiting
Chongqing University Three Gorges HospitalChongqing, ChinaNot Yet Recruiting
The First People's Hospital of FoshanFoshan, ChinaNot Yet Recruiting
Fujian Medical University Union HospitalFuzhou, ChinaNot Yet Recruiting
Affiliated Cancer Hospital of Guangzhou Medical UniversityGuangzhou, ChinaNot Yet Recruiting
Nanfang Hospital Southern Medical UniversityGuangzhou, ChinaNot Yet Recruiting
Guangdong Provincial People's HospitalGuanzhou, ChinaRecruiting
The Second Affiliated Hospital Zhejiang University School of MedicineHangzhou, ChinaNot Yet Recruiting
The First Affiliated Hospital of USTC Anhui Provincial HospitalHefei, ChinaNot Yet Recruiting
The Affiliated Hospital of Inner Mongolia HospitalHohhot, ChinaNot Yet Recruiting
The Affiliated Hospital of Qingdao UniversityQingdao, ChinaNot Yet Recruiting
Zhongshan Hospital Fudan UniversityShanghai, ChinaNot Yet Recruiting

+ 4 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05536505